ORIGINAL RESEARCH
Noninvasive preimplantation genetic testing for aneuploidy
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
Correspondence should be addressed: Olga I. Lisitsyna
Akademika Oparina, 4, Moscow, 117997, Russia; ur.xobni@avokyzay_o
Funding: the study was supported by the Russian Foundation for Basic Research under research project №23-25-00346.
Author contribution: Makarova NP, Lisitsyna OI, Dolgushina NV — study concept and design; Lisitsyna OI, Makarova NP, Dolgushina NV, Syrkasheva AG, Ekimov AN — manuscript writing and editing; Lisitsyna OI — statistical processing of the results; Goryainova EG, Makarova NP — biomaterial collection; Ekimov AN, Atapina EE — laboratory phase; Dolgushina NV, Trofimov DYu — publication approval.
Compliance with ethical standards: the study was approved by the Ethics Committee of the Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology (protocol № 10 of 28 October 2021). The patients submitted the informed consent to study participation.
- Sciorio R, Tramontano L, Catt J. Preimplantation genetic diagnosis (PGD) and genetic testing for aneuploidy (PGT-A): status and future challenges. Gynecol. Endocrinol. 2020; 36 (1): 6–11.
- Malysheva OV, Pendina AA, Efimova OA, Chiryaeva OG. Predymplantacionnoe geneticheskoe testirovanie. V knige: Kogan I. Yu., redaktor. Ehkstrakorporal'noe oplodotvorenie: prakticheskoe rukovodstvo dlya vrachej. M.: GEhOTAR-Media, 2021; s. 357–67. Russian.
- Zhigalina DI, Skryabin NA, Kanbekova OR, Artyukhova VG, Svetlakov AV, Lebedev IN. Comparative cytogenetics of embryoblast, trophectoderm and blastocoele fluid of human blastocyst. Medical Genetics. 2018; 17 (2): 46–52. Russian.
- Makarova NP, Ekimov AN, Kulakova EV, Drapkina YuS, Sysoeva AP, Krasnova NA, et. al. Characteristics of embryonic mosaicism in infertility treatment with assisted reproductive technologies. Obstetrics and gynecology. 2021; (7): 144–51. Russian.
- Navarro-Sánchez L, García-Pascual C, Rubio C, Simón C. Noninvasive preimplantation genetic testing for aneuploidies: an update. Reprod. Biomed. Online. 2022; 44 (5): 817–28.
- Brouillet S, Martinez G, Coutton C, Hamamah S. Is cell-free DNA in spent embryo culture medium an alternative to embryo biopsy for preimplantation genetic testing? A systematic review. Reprod. Biomed. Online. 2020; 40 (6): 779–6.
- Lisitsyna OI, Makarova NP, Dolgushina NV. Evaluation of extracellular DNA as a method for non-invasive preimplantation genetic testing of embryos in infertility treatment programs using assisted reproductive technologies. Obstetrics and gynecology. 2022; (6): 13–19. Russian.
- Rubio C, Navarro-Sánchez L, García-Pascual CM, Ocali O, Cimadomo D, Venier W, et al. Multicenter prospective study of concordance between embryonic cell-free DNA and trophectoderm biopsies from 1301 human blastocysts. Am J Obstet Gynecol. 2020; 223 (5): 751.e1–13.
- Huang L, Bogale B, Tang Y, Lu S, Xie XS, Racowsky C. Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsy. Proc Natl Acad Sci USA. 2019; 116 (28): 14105–12.
- Rubio C, Racowsky C, Barad DH, Scott RT, Simon C. Noninvasive preimplantation genetic testing for aneuploidy in spent culture medium as a substitute for trophectoderm biopsy. Fertil Steril. 2021; 115 (4): 841–9.
- Tomic M, Vrtacnik Bokal E, Stimpfel M. Non-invasive preimplantation genetic testing for aneuploidy and the mystery of genetic material: a review article. Int J Mol Sci. 2022; 23 (7): 3568.
- Makarova NP, Lisitsyna OI, Nepsha OS, Krasnyi AM, Sadekova AA, Nezlina AL, et al. Mitichondrial DNA expression profile in embryo culture medium in assisted reproductive technology. Obstetrics and gynecology. 2022; (3): 89–96. Russian.
- Chen L, Sun Q, Xu J, Fu H, Liu Y, Yao Y, et al. A Non-invasive Chromosome Screening Strategy for Prioritizing in vitro Fertilization Embryos for Implantation. Front Cell Dev Biol. 2021; 9: 708322.
- Ho JR, Arrach N, Rhodes-Long K, Ahmady A, Ingles S, Chung K, et al. Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos. Fertil Steril. 2018; 110 (3): 467–475.e2.
- Rubio C, Rienzi L, Navarro-Sánchez L, Cimadomo D, GarcíaPascual CM, Albricci L, et al. Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications. Fertil Steril. 2019; 112 (3): 510–19.
- Vera-Rodriguez M, Diez-Juan A, Jimenez-Almazan J, Martinez S, Navarro R, Peinado V, et al. Origin and composition of cellfree DNA in spent medium from human embryo culture during preimplantation development. Hum Reprod. 2018; 33 (4): 745–56.
- Yeung QSY, Zhang YX, Chung JPW, Lui WT, Kwok YKY, Gui B, et al. A prospective study of non-invasive preimplantation genetic testing for aneuploidies (NiPGT-A) using next-generation sequencing (NGS) on spent culture media (SCM). J Assist Reprod Genet. 2019; 36 (8): 1609–21.
- Xu J, Fang R, Chen L, Chen D, Xiao JP, Yang W, et al. Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization. Proc Natl Acad Sci USA. 2016; 113 (42): 11907–12.
- Yin B, Zhang H, Xie J, Wei Y, Zhang C, Meng L. Validation of preimplantation genetic tests for aneuploidy (PGT-A) with DNA from spent culture media (SCM): concordance assessment and implication. Reprod Biol Endocrinol. 2021; 19 (1): 41.
- Shitara A, Takahashi K, Goto M, Takahashi H, Iwasawa T, Onodera Y, et al. Cell-free DNA in spent culture medium effectively reflects the chromosomal status of embryos following culturing beyond implantation compared to trophectoderm biopsy. PLoS One. 2021; 16 (2): e0246438.
- Xu CL, Wei YQ, Tan QY, Huang Y, Wu JJ, Li CY, et al. Concordance of PGT for aneuploidies between blastocyst biopsies and spent blastocyst culture medium. Reprod Biomed. 2023; 46 (3): 483–90.
- Li X, Hao Y, Chen D, Ji D, Zhu W, Zhu X, et al. Non-invasive preimplantation genetic testing for putative mosaic blastocysts: a pilot study. Hum Reprod. 2021; 36 (7): 2020–34.
- Chen R, Tang N, Du H, Yao Y, Zou Y, Wang J, et al. Clinical application of noninvasive chromosomal screening for elective single-blastocyst transfer in frozen-thawed cycles. J Transl Med. 2022; 20 (1): 553.
- Rubio C, Simón C. Noninvasive preimplantation genetic testing for aneuploidy: Is the glass half-empty or half-full? Fertil Steril. 2021; 115 (6): 1426–7.
- Kakourou G, Mamas T, Vrettou C, Traeger-Synodinos J. An Update on Non-invasive Approaches for Genetic Testing of the Preimplantation Embryo. Curr Genomics. 2022; 23 (5): 337–52.
- Alteri A, Cermisoni GC, Pozzoni M, Gaeta G, Cavoretto PI, Viganò P. Obstetric, neonatal, and child health outcomes following embryo biopsy for preimplantation genetic testing. Hum Reprod Updat. 2023; 29 (3): 291–306.
- Makhijani R, Bartels CB, Godiwala P, Bartolucci A, DiLuigi A, Nulsen J, et al. Impact of trophectoderm biopsy on obstetric and perinatal outcomes following frozen-thawed embryo transfer cycles. Hum Reprod. 2021; 36 (2): 340–8.
- Awadalla MS, Park KE, Latack KR, McGinnis LK, Ahmady A, Paulson RJ. Influence of Trophectoderm Biopsy Prior to Frozen Blastocyst Transfer on Obstetrical Outcomes. Reprod Sci. 2021; 28 (12): 3459–65.
- He H, Jing S, Lu CF, Tan YQ, Luo KL, Zhang SP, et al. Neonatal outcomes of live births after blastocyst biopsy in preimplantation genetic testing cycles: a follow-up of 1,721 children. Fertil Steril. 2019; 112 (2): 82–88.
- Swanson K, Huang D, Kaing A, Blat C, Rosenstein MG, MokLin E, et al. Is Preimplantation Genetic Testing Associated with Increased Risk of Abnormal Placentation After Frozen Embryo Transfer? Am J Perinatol. 2021; 38 (2): 105–10.